A Chat with Daniel Mansson, Founder at HealthTech Company: Flow Neuroscience
Flow Neuroscience is a health technology company focused on providing treatment for depression through a combination of a brain stimulation headset and a therapy app. The headset employs transcranial direct-current stimulation (tDCS) to target the…
Flow Neuroscience is a health technology company focused on providing treatment for depression through a combination of a brain stimulation headset and a therapy app. The headset employs transcranial direct-current stimulation (tDCS) to target the dorsolateral prefrontal cortex, a brain area involved in mood regulation. The companion app offers behavioral therapy based on scientific evidence.
Currently, over 50,000 individuals and more than 600 clinicians and hospitals across Europe utilize Flow. Clinical studies indicate that approximately 77% of users experience significant improvement within three weeks, and over half achieve freedom from depression after ten weeks.
A medical-grade headset that applies mild electrical currents to the brain, promoting healthy activity patterns. An app that provides users with evidence-based behavioral therapy, focusing on areas such as sleep, nutrition, exercise, and meditation.
The headset employs transcranial direct-current stimulation (tDCS) to target the dorsolateral prefrontal cortex, a brain area involved in mood regulation.
The device is the first medically certified tDCS device approved for home use in the UK and EU. It can be utilized independently or alongside medication and therapy, providing a side-effect-free alternative to antidepressants for many users.
Flow Neuroscience is committed to expanding clinical research and increasing product availability. The device has received Breakthrough Device designation from the FDA, marking progress toward U.S. approval. The company is also collaborating with healthcare systems, such as the NHS, to integrate Flow into standard treatment procedures. The long-term goal is to establish Flow as a primary treatment for depression, combining neuromodulation with behavioral and digital interventions. The development of the next-generation device is expected to significantly enhance efficacy.
Flow Neuroscience aims to empower individuals globally to manage their mental health effectively.
Based on reporting by techround.co.uk.
